Global Insulin Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5686293   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Insulin is a hormone produced by the pancreas that plays a critical role in regulating blood sugar levels in the body. It acts as a key that allows glucose from the bloodstream to enter cells, where it is used as energy or stored for future use. In individuals with diabetes, either the pancreas does not produce enough insulin (Type 1 diabetes) or the body's cells become resistant to insulin's effects (Type 2 diabetes), leading to high blood sugar levels. Insulin therapy, administered through injections or insulin pumps, is a cornerstone of diabetes management, helping to control blood sugar levels and prevent complications associated with the disease. Additionally, insulin plays a role in regulating metabolism, promoting the storage of nutrients, and influencing various physiological processes throughout the body.
According to DIResearch's in-depth investigation and research, the global Insulin market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Insulin include Novo Nordisk, Sanofi, Eli Lilly, Biocon, Pfizer, Wockhardt, Julphar, Exir, Sedico etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Insulin. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Insulin market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Insulin market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Insulin industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Insulin Include:
Novo Nordisk
Sanofi
Eli Lilly
Biocon
Pfizer
Wockhardt
Julphar
Exir
Sedico
Insulin Product Segment Include:
Basal or Long-acting Insulins
Bolus or Fast-acting Insulins
Traditional Human Insulins
Combination Insulins
Biosimilar Insulins
Insulin Product Application Include:
Hospital
Household
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Insulin Industry PESTEL Analysis
Chapter 3: Global Insulin Industry Porter's Five Forces Analysis
Chapter 4: Global Insulin Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Insulin Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Insulin Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Insulin Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 Insulin Market Overview

1.1 Product Definition and Statistical Scope

1.2 Insulin Product by Type

1.2.1 Global Insulin Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Basal or Long-acting Insulins

1.2.3 Bolus or Fast-acting Insulins

1.2.4 Traditional Human Insulins

1.2.5 Combination Insulins

1.2.6 Biosimilar Insulins

1.3 Insulin Product by Application

1.3.1 Global Insulin Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Household

1.4 Global Insulin Market Revenue and Sales Analysis

1.4.1 Global Insulin Market Size Analysis (2019-2030)

1.4.2 Global Insulin Market Sales Analysis (2019-2030)

1.4.3 Global Insulin Market Sales Price Trend Analysis (2019-2030)

1.5 Insulin Market Development Status and Trends

1.5.1 Insulin Industry Development Status Analysis

1.5.2 Insulin Industry Development Trends Analysis

2 Insulin Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Insulin Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Insulin Market Analysis by Regions

4.1 Insulin Overall Market: 2023 VS 2024 VS 2030

4.2 Global Insulin Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Insulin Revenue and Market Share by Region (2019-2024)

4.2.2 Global Insulin Revenue Forecast by Region (2025-2030)

4.3 Global Insulin Sales and Forecast Analysis (2019-2030)

4.3.1 Global Insulin Sales and Market Share by Region (2019-2024)

4.3.2 Global Insulin Sales Forecast by Region (2025-2030)

4.4 Global Insulin Sales Price Trend Analysis (2019-2030)

5 Global Insulin Market Size by Type and Application

5.1 Global Insulin Market Size by Type

5.1.1 Global Insulin Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Insulin Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Insulin Market Size by Application

5.2.1 Global Insulin Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Insulin Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Insulin Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Insulin Market Size by Type

6.3.1 North America Insulin Sales by Type (2019-2030)

6.3.2 North America Insulin Revenue by Type (2019-2030)

6.4 North America Insulin Market Size by Application

6.4.1 North America Insulin Sales by Application (2019-2030)

6.4.2 North America Insulin Revenue by Application (2019-2030)

6.5 North America Insulin Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Insulin Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Insulin Market Size by Type

7.3.1 Europe Insulin Sales by Type (2019-2030)

7.3.2 Europe Insulin Revenue by Type (2019-2030)

7.4 Europe Insulin Market Size by Application

7.4.1 Europe Insulin Sales by Application (2019-2030)

7.4.2 ? Europe Insulin Revenue by Application (2019-2030)

7.5 Europe Insulin Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Insulin Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Insulin Market Size by Type

8.3.1 China Insulin Sales by Type (2019-2030)

8.3.2 China Insulin Revenue by Type (2019-2030)

8.4 China Insulin Market Size by Application

8.4.1 China Insulin Sales by Application (2019-2030)

8.4.2 China Insulin Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Insulin Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Insulin Market Size by Type

9.3.1 APAC (excl. China) Insulin Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Insulin Revenue by Type (2019-2030)

9.4 APAC (excl. China) Insulin Market Size by Application

9.4.1 APAC (excl. China) Insulin Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Insulin Revenue by Application (2019-2030)

9.5 APAC (excl. China) Insulin Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Insulin Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Insulin Market Size by Type

10.3.1 Latin America Insulin Sales by Type (2019-2030)

10.3.2 Latin America Insulin Revenue by Type (2019-2030)

10.4 Latin America Insulin Market Size by Application

10.4.1 Latin America Insulin Sales by Application (2019-2030)

10.4.2 Latin America Insulin Revenue by Application (2019-2030)

10.5 Latin America Insulin Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Insulin Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Insulin Market Size by Type

11.3.1 Middle East & Africa Insulin Sales by Type (2019-2030)

11.3.2 Middle East & Africa Insulin Revenue by Type (2019-2030)

11.4 Middle East & Africa Insulin Market Size by Application

11.4.1 Middle East & Africa Insulin Sales by Application (2019-2030)

11.4.2 Middle East & Africa Insulin Revenue by Application (2019-2030)

11.5 Middle East & Africa Insulin Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Insulin Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Insulin Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Insulin Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Insulin Average Sales Price by Manufacturers (2020-2024)

12.2 Insulin Competitive Landscape Analysis and Market Dynamic

12.2.1 Insulin Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Novo Nordisk Insulin Product Portfolio

13.1.3 Novo Nordisk Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Sanofi

13.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Sanofi Insulin Product Portfolio

13.2.3 Sanofi Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Eli Lilly

13.3.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Eli Lilly Insulin Product Portfolio

13.3.3 Eli Lilly Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Biocon

13.4.1 Biocon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Biocon Insulin Product Portfolio

13.4.3 Biocon Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Pfizer

13.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Pfizer Insulin Product Portfolio

13.5.3 Pfizer Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Wockhardt

13.6.1 Wockhardt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Wockhardt Insulin Product Portfolio

13.6.3 Wockhardt Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Julphar

13.7.1 Julphar Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Julphar Insulin Product Portfolio

13.7.3 Julphar Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Exir

13.8.1 Exir Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Exir Insulin Product Portfolio

13.8.3 Exir Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Sedico

13.9.1 Sedico Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Sedico Insulin Product Portfolio

13.9.3 Sedico Insulin Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Insulin Industry Chain Analysis

14.2 Insulin Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Insulin Typical Downstream Customers

14.4 Insulin Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support